Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, Scholten D, Berres ML, Zimmermann H, Streetz KL, Tacke F, Hillebrandt S, Schmitz P, Keppeler H, Berg T, Dahl E, Gassler N, Friedman SL, Trautwein C.
Wasmuth HE, et al. Among authors: streetz kl.
Gastroenterology. 2009 Jul;137(1):309-19, 319.e1-3. doi: 10.1053/j.gastro.2009.03.053. Epub 2009 Apr 1.
Gastroenterology. 2009.
PMID: 19344719
Free PMC article.